Redirection Hypothesis Alzheimers

Read full text Summarise with VIRAT
Authors: Mart Wijn
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT Alzheimer’s disease is the most prevalent neurodegenerative condition globally, affecting an estimated 55 million people worldwide and projected to exceed 130 million by 2050. The dominant research paradigm has focused for over three decades on the amyloid cascade hypothesis: the proposition that accumulation of amyloid-beta plaques in the brain initiates the disease process and that removing or preventing these plaques will halt cognitive decline. Despite enormous investment, this approach has produced no curative therapy. The most successful amyloid-targeting treatments achieve modest plaque reduction with marginal clinical benefit and significant adverse effects. This paper applies the Redirection Hypothesis — a framework proposing that neurodegenerative diseases are better understood as downstream consequences of upstream biological chain failures — specifically to Alzheimer’s disease. Drawing on epidemiological evidence from geographically and culturally distinct populations, current findings in neuroinflammation, astrocyte and microglial biology, epigenetics, gut-brain axis research, and blood-based biomarker science, this paper argues that amyloid plaque accumulation in Alzheimer’s is a late-stage symptom of processes originating years or decades earlier in the biological chain. A critical additional dimension is proposed: the Default Mode Network (DMN) — the brain system responsible for autobiographical memory, self-referential thought, and the continuous internal narrative — is the first and most severely affected network in Alzheimer’s disease. This paper presents a first-person consciousness perspective from an individual who has functioned for over seven years with a structurally deactivated DMN, demonstrating that full cognitive and emotional functioning is possible without DMN dominance. This observation raises a fundamental question: is the catastrophic impact of Alzheimer’s a consequence of neuronal destruction alone, or does it reflect the collapse of a cognitive system upon which modern humans have become exclusively dependent? Finally, this paper proposes a population-level early detection model based on recently validated blood biomarkers — including phosphorylated tau-217, amyloid-beta ratios, neurofilament light chain, and glial fibrillary acidic protein — combined with lifestyle-focused intervention for elevated values, as a low-cost, low-risk strategy for delaying or preventing threshold crossing from subclinical neuronal stress to clinical Alzheimer’s disease.

Fields of Study & Subjects

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
21 March 2026
Language
EN